Select a medication above to begin.
Imuran
azathioprine
Black Box Warnings .
Malignancy Risk
chronic immunosuppression w/ azathioprine incr. malignancy risk incl. post-transplant lymphoma and hepatosplenic T-cell lymphoma in pts w/ inflammatory bowel dz
Serious Adverse Effects
mutagenic potential to both men and women; hematologic toxicities possible
Adult Dosing .
Dosage forms: TAB: 50 mg
kidney transplant rejection prophylaxis
- [1-3 mg/kg/dose PO qd]
- Start: 3-5 mg/kg/dose PO x1 up to 3 days before transplant; Info: transplant protocols may vary; decr. dose if heterozygous TPMT and/or nucleotide diphosphatase (NUDT15) deficiency, consider alternative tx if homozygous TPMT or NUDT15 deficiency
rheumatoid arthritis, severe
- [1-2.5 mg/kg/day PO divided qd-bid]
- Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk; decr. dose if heterozygous TPMT and/or nucleotide diphosphatase (NUDT15) deficiency, consider alternative tx if homozygous TPMT or NUDT15 deficiency
Crohn dz (off-label)
- [100-250 mg PO qd]
- Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance and fistulizing dz, steroid-sparing effects; decr. dose if heterozygous TPMT and/or nucleotide diphosphatase (NUDT15) deficiency, consider alternative tx if homozygous TPMT or NUDT15 deficiency
ulcerative colitis (off-label)
- [100-250 mg PO qd]
- Start: 50 mg PO qd; Max: 2.5 mg/kg/day; Info: for induction or remission maintenance, steroid-sparing effects; decr. dose if heterozygous TPMT and/or nucleotide diphosphatase (NUDT15) deficiency, consider alternative tx if homozygous TPMT or NUDT15 deficiency
renal dosing
- [adjust dose amount]
- CrCl 10-50: decr. usual dose by 25%; CrCl <10: decr. usual dose by 50%
- HD: decr. usual dose by 50%; give 0.25 mg/kg/dose supplement after dialysis if next maint. dose not due right after dialysis; PD: not defined
hepatic dosing
- [see below]
- hepatic impairment: not defined, caution advised
Peds Dosing .
- Dosage forms: TAB: 50 mg
kidney transplant rejection prophylaxis (off-label)
- [1-3 mg/kg/dose PO qd]
- Start: 3-5 mg/kg/dose PO x1 up to 3 days before transplant; Info: transplant protocols may vary; decr. dose if heterozygous TPMT and/or nucleotide diphosphatase (NUDT15) deficiency, consider alternative tx if homozygous TPMT or NUDT15 deficiency
juvenile idiopathic arthritis, severe (off-label)
- [1-2.5 mg/kg/day PO divided qd-bid]
- Start: 1 mg/kg/day PO divided qd-bid; Max: 2.5 mg/kg/day; Info: after 6-8wk may incr. 0.5 mg/kg/day q4wk; decr. dose if heterozygous TPMT and/or nucleotide diphosphatase (NUDT15) deficiency, consider alternative tx if homozygous TPMT or NUDT15 deficiency
renal dosing
- [adjust dose amount, frequency]
- CrCl 10-50: decr. usual dose by 25%; CrCl <10: decr. usual dose by 50%
- HD: decr. usual dose by 50%; no supplement after dialysis; PD: not defined
hepatic dosing
- [see below]
- hepatic impairment: not defined, caution advised